← Eichor
Condition: Stroke Prevention In Patients With Atrial Fibrillation Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Stroke Prevention In Patients With Atrial Fibrillation

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Early Atrial Fibrillation Ablation for Stroke Prevention in Patients With High Comorbidity Burden (EASThigh-AFNET 11)
NA · 7 location(s) · Atrial Fibrillation Network · NCT06324188Stroke Prophylaxis With Apixaban in Chronic Kidney Disease Stage 5 Patients With Atrial Fibrillation
Phase 3 · 34 location(s) · Region Stockholm · NCT05679024Stroke Risk Assessment and Markers of Blood Clotting in Patients With Newly Diagnosed Non-valvular Atrial Fibrillation (
Phase N/A · 1 location(s) · Nedim Tojaga · NCT06949319Left Atrial Appendage Closure as Secondary Prevention of Atrial Fibrillation-related Embolic Events
Phase N/A · 5 location(s) · Lifetech Scientific (Shenzhen) Co., Ltd. · NCT04559243OPTION-EMEA Clinical Trial
NA · 3 location(s) · Boston Scientific Corporation · NCT07349121Carotid Implants for PreveNtion of STrokE ReCurrEnce From Large Vessel Occlusion in Atrial Fibrillation Patients Treated
NA · 7 location(s) · Javelin Medical · NCT05723926Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With
Phase 4 · 105 location(s) · Population Health Research Institute · NCT03968393COmparison of Bleeding Risk Between Rivaroxaban and Apixaban in Patients With Atrial Fibrillation
Phase 4 · 8 location(s) · Ottawa Hospital Research Institute · NCT04642430CLOT-LESS - CLOsure Tailored: LEss Antithrombotic Strategy After LAAC for Stroke Prevention
Phase N/A · 1 location(s) · National Medical Research Center for Therapy and Preventive · NCT07575867
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.